Clinical Trials Directory

Trials / Completed

CompletedNCT00288587

Extracorporeal Ultrafiltration (UF) vs. Usual and Customary Care for Patients With Severe Heart Failure (HF)

CP0007: Extracorporeal Ultrafiltration (UF) vs. Usual and Customary Care for Patients With Severe Heart Failure (HF)

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
36 (actual)
Sponsor
NxStage Medical · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to assess the ability of Ultrafiltration to influence the rate of hemodynamic improvement, as measured by the decline in the pulmonary artery occlusion pressure, in patients with NYHA class III/IV Heart Failure.

Detailed description

This study will be preformed in a specialized heart failure unit at the Cleveland Clinic Foundation (CCF) and will include both the UF-treated group and a control group receiving usual and customary care. Patients will be stratified according to renal function at the time of admission. Therapies will be guided by specific hemodynamic criteria routinely used at the study institution.

Conditions

Interventions

TypeNameDescription
DRUGIV loop diureticUse of conventional diuretic therapy upon hospital admission for treatment of decompensated heart failure.
DEVICENxStage System OnePatients treated with Extracorporeal Ultrafiltration upon hospital admission for treatment of decompensated heart failure.

Timeline

Start date
2003-10-01
Primary completion
2008-09-01
Completion
2009-01-01
First posted
2006-02-08
Last updated
2012-06-19
Results posted
2012-06-19

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00288587. Inclusion in this directory is not an endorsement.